Operating
Change in AP
Pfizer Change in AP remained flat by 0.0% to -$117.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 54.2%, from -$255.75M to -$117.25M. Over 4 years (FY 2021 to FY 2025), Change in AP shows a downward trend with a -21.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalHigher is better
VolatilityVolatile
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
An increase suggests the company is successfully leveraging its scale to negotiate better payment terms with its supply chain.
Detailed definition
Accounts payable represents the change in the amount the company owes to its suppliers for materials or services purchas...
Peer comparison
Dominant market leaders often have high accounts payable as they can dictate longer payment terms to their vendors.
Metric ID:
cf_change_in_accounts_payableHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $1.24B | $1.19B | -$300.00M | -$1.02B | -$469.00M |
| YoY Change | — | -4.1% | -125.2% | -241.0% | +54.2% |
Range-$1.02B – $1.24B
CAGR-21.6%
Avg YoY Growth-79.0%
Median YoY Growth-64.6%
Change in AP at Other Companies
Frequently Asked Questions
- What is Pfizer's change in ap?
- Pfizer (PFE) reported change in ap of -$117.25M in Q4 2025.
- How has Pfizer's change in ap changed year-over-year?
- Pfizer's change in ap increased by 54.2% year-over-year, from -$255.75M to -$117.25M.
- What is the long-term trend for Pfizer's change in ap?
- Over 4 years (2021 to 2025), Pfizer's change in ap has grown at a -21.6% compound annual growth rate (CAGR), from $1.24B to -$469.00M.
- What does change in ap mean?
- The change in the amount of money the company owes to its suppliers.